Advertisement

Topics

Physicist reports binary marker of preclinical and clinical Alzheimer's disease

03:20 EDT 23 Aug 2017 | Medical Xpress

A new technique shows high potential for providing a discrete, non-invasive biomarker of Alzheimer's disease (AD) at the individual level during both preclinical and clinical stages. The proposed biomarker has a large effect size (0.9) and high accuracy, sensitivity and specificity (100 percent) in identifying symptomatic AD patients within a research sample, according to Sanja Josef Golubić Ph.D. of the University of Zagreb. He is the leading author of a new study published in the neuroimaging journal Human Brain Mapping.

Original Article: Physicist reports binary marker of preclinical and clinical Alzheimer's disease

NEXT ARTICLE

More From BioPortfolio on "Physicist reports binary marker of preclinical and clinical Alzheimer's disease"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Neurology - Central Nervous System (CNS)
Alzheimer's Disease Anesthesia Anxiety Disorders Autism Bipolar Disorders Dementia Epilepsy Multiple Sclerosis (MS) Neurology Pain Parkinson's Disease Sleep Disorders Neurology is the branch of me...